On Tuesday, Avita Medical, Inc. (NASDAQ:RCEL) revised its revenue guidance for the fourth quarter and full year of 2024. The regenerative medicine company adjusted its projections due to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback